Myriad Genetics (MYGN) Quick Ratio: History & Chart

Myriad Genetics, Inc.(MYGN)

Medical - Diagnostics & Research · Salt Lake City, UT

$4.28-0.30 (-6.55%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Salt Lake City, UT

2,700 employees

www.myriad.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Samraat S. Raha

View full financials

MYGN Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.98

QUICK RATIO (ACID-TEST) AVG TTM

1.96

QUICK RATIO (ACID-TEST) AVG 3Y

1.80

QUICK RATIO (ACID-TEST) AVG 5Y

1.95

QUICK RATIO (ACID-TEST) AVG 10Y

2.21

QUICK RATIO (ACID-TEST) AVG 15Y

3.03

QUICK RATIO (ACID-TEST) AVG 20Y

4.69

CURRENT VS TTM AVG

+0.69%

CURRENT VS 3Y AVG

+9.78%

CURRENT VS 5Y AVG

+1.59%

CURRENT VS 10Y AVG

-10.43%

CURRENT VS 15Y AVG

-34.69%

CURRENT VS 20Y AVG

-57.87%

SECTOR MEDIAN · HEALTHCARE

3.35

median of 870 covered companies

CURRENT VS SECTOR MEDIAN

-41.07%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Myriad Genetics, Inc. (MYGN)	$404.24M	1.98	1.96	1.80	1.95
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$405.74M	8.13	16.34	21.67	17.16
Neurogene Inc. (NGNE)vs ›	$402.17M	10.64	18.70	14.71	15.03
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$406.58M	9.89	6.34	6.34	6.34
Carlsmed, Inc. (CARL)vs ›	$397.99M	8.66	7.11	5.24	5.24
Strata Critical Medical, Inc. (SRTA)vs ›	$411.00M	2.64	6.72	6.86	10.10
MapLight Therapeutics, Inc. (MPLT)vs ›	$411.21M	16.52	13.61	8.86	8.86
Shoulder Innovations, Inc. (SI)vs ›	$396.93M	8.92	6.16	7.06	7.06
Rezolute, Inc. (RZLT)vs ›	$415.98M	9.44	11.90	14.34	23.42
Senseonics Holdings, Inc. (SENS)vs ›	$416.27M	6.40	3.40	4.68	4.62

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Myriad Genetics, Inc. (MYGN)

$404.24M

1.98

1.96

1.80

1.95

Atea Pharmaceuticals, Inc. (AVIR)vs ›

$405.74M

8.13

16.34

21.67

17.16

Neurogene Inc. (NGNE)vs ›

$402.17M

10.64

18.70

14.71

15.03

Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›

$406.58M

9.89

6.34

Carlsmed, Inc. (CARL)vs ›

$397.99M

8.66

7.11

5.24

Strata Critical Medical, Inc. (SRTA)vs ›

$411.00M

2.64

6.72

6.86

10.10

MapLight Therapeutics, Inc. (MPLT)vs ›

$411.21M

16.52

13.61

8.86

Shoulder Innovations, Inc. (SI)vs ›

$396.93M

8.92

6.16

7.06

Rezolute, Inc. (RZLT)vs ›

$415.98M

9.44

11.90

14.34

23.42

Senseonics Holdings, Inc. (SENS)vs ›

$416.27M

6.40

3.40

4.68

4.62

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The quick ratio (acid-test) for MYGN stock is 1.98.

Is Myriad Genetics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 1.98 is in line with its 5-year average of 1.95, around the middle of its 5-year range (1.15–2.94).

What is the TTM average quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The TTM average quick ratio (acid-test) for MYGN stock is 1.96.

What is the 3Y average quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The 3Y average quick ratio (acid-test) for MYGN stock is 1.80.

What is the 5Y average quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The 5Y average quick ratio (acid-test) for MYGN stock is 1.95.

What is the 10Y average quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The 10Y average quick ratio (acid-test) for MYGN stock is 2.21.

What is the 15Y average quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The 15Y average quick ratio (acid-test) for MYGN stock is 3.03.

What is the 20Y average quick ratio (acid-test) for Myriad Genetics, Inc. (MYGN)?

The 20Y average quick ratio (acid-test) for MYGN stock is 4.69.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	1.98
2026-03-31	2.19
2025-12-31	2.26
2025-09-30	2.12
2025-06-30	1.28
2025-03-31	1.71
2024-12-31	1.65
2024-09-30	1.73
2024-06-30	1.78
2024-03-31	1.82
2023-12-31	1.87
2023-09-30	1.15
2023-06-30	1.23
2023-03-31	1.67
2022-12-31	1.85
2022-09-30	2.58
2022-06-30	2.94
2022-03-31	2.48
2021-12-31	2.30
2021-09-30	2.36
2021-06-30	1.92
2021-03-31	2.04
2020-12-31	2.48
2020-09-30	2.75
2020-06-30	2.06
2020-03-31	2.87
2019-12-31	3.00
2019-09-30	2.61
2019-06-30	2.69
2019-03-31	2.86
2018-12-31	2.68
2018-09-30	2.83
2018-06-30	2.87
2018-03-31	3.16
2017-12-31	1.81
2017-09-30	2.06
2017-06-30	1.19
2017-03-31	1.36
2016-12-31	3.51
2016-09-30	0.98
2016-06-30	3.82
2016-03-31	5.25
2015-12-31	5.26
2015-09-30	4.63
2015-06-30	3.76
2015-03-31	3.77
2014-12-31	5.01
2014-09-30	4.59
2014-06-30	3.70
2014-03-31	4.42
2013-12-31	6.74
2013-09-30	5.80
2013-06-30	7.43
2013-03-31	8.22
2012-12-31	9.82
2012-09-30	7.40
2012-06-30	9.14
2012-03-31	11.02
2011-12-31	12.05
2011-09-30	13.06
2011-06-30	11.92
2011-03-31	17.78
2010-12-31	19.18
2010-09-30	15.90
2010-06-30	17.26
2010-03-31	20.28
2009-12-31	17.65
2009-09-30	19.55
2009-06-30	11.38
2009-03-31	12.51
2008-12-31	7.00
2008-09-30	6.75
2008-06-30	5.12
2008-03-31	6.72
2007-12-31	6.58
2007-09-30	7.37
2007-06-30	7.18
2007-03-31	14.58
2006-12-31	8.85
2006-09-30	10.36
2006-06-30	9.41
2006-03-31	11.76
2005-12-31	11.10
2005-09-30	5.70
2005-06-30	5.82
2005-03-31	6.09
2004-12-31	6.29
2004-09-30	8.32
2004-06-30	9.10
2004-03-31	6.30
2003-12-31	7.07
2003-09-30	8.04
2003-06-30	5.32
2003-03-31	9.38
2002-12-31	6.17
2002-09-30	4.50

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

1.98

2026-03-31

2.19

2025-12-31

2.26

2025-09-30

2.12

2025-06-30

1.28

2025-03-31

1.71

2024-12-31

1.65

2024-09-30

1.73

2024-06-30

1.78

2024-03-31

1.82

2023-12-31

1.87

2023-09-30

1.15

2023-06-30

1.23

2023-03-31

1.67

2022-12-31

1.85

2022-09-30

2.58

2022-06-30

2.94

2022-03-31

2.48

2021-12-31

2.30

2021-09-30

2.36

2021-06-30

1.92

2021-03-31

2.04

2020-12-31

2.48

2020-09-30

2.75

2020-06-30

2.06

2020-03-31

2.87

2019-12-31

3.00

2019-09-30

2.61

2019-06-30

2.69

2019-03-31

2.86

2018-12-31

2.68

2018-09-30

2.83

2018-06-30

2.87

2018-03-31

3.16

2017-12-31

1.81

2017-09-30

2.06

2017-06-30

1.19

2017-03-31

1.36

2016-12-31

3.51

2016-09-30

0.98

2016-06-30

3.82

2016-03-31

5.25

2015-12-31

5.26

2015-09-30

4.63

2015-06-30

3.76

2015-03-31

3.77

2014-12-31

5.01

2014-09-30

4.59

2014-06-30

3.70

2014-03-31

4.42

2013-12-31

6.74

2013-09-30

5.80

2013-06-30

7.43

2013-03-31

8.22

2012-12-31

9.82

2012-09-30

7.40

2012-06-30

9.14

2012-03-31

11.02

2011-12-31

12.05

2011-09-30

13.06

2011-06-30

11.92

2011-03-31

17.78

2010-12-31

19.18

2010-09-30

15.90

2010-06-30

17.26

2010-03-31

20.28

2009-12-31

17.65

2009-09-30

19.55

2009-06-30

11.38

2009-03-31

12.51

2008-12-31

7.00

2008-09-30

6.75

2008-06-30

5.12

2008-03-31

6.72

2007-12-31

6.58

2007-09-30

7.37

2007-06-30

7.18

2007-03-31

14.58

2006-12-31

8.85

2006-09-30

10.36

2006-06-30

9.41

2006-03-31

11.76

2005-12-31

11.10

2005-09-30

5.70

2005-06-30

5.82

2005-03-31

6.09

2004-12-31

6.29

2004-09-30

8.32

2004-06-30

9.10

2004-03-31

6.30

2003-12-31

7.07

2003-09-30

8.04

2003-06-30

5.32

2003-03-31

9.38

2002-12-31

6.17

2002-09-30

4.50

Quick Ratio (Acid-Test): 1.98

MYGN Quick Ratio

MYGN Average Quick Ratio (Acid-Test) Chart

MYGN Current vs Average Quick Ratio (Acid-Test) Chart

MYGN Quick Ratio (Acid-Test) Metrics

MYGN Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

MYGN Quick Ratio (Acid-Test) History

Related Metrics